Search

Board elections

Shape the future of EHA by taking part in our 2025 Board election. Nominations closed on February 9, 2025. The ballot will open on April 8, 2025.

Read more

7th European CAR T-cell Meeting

The European Hematology Association (EHA) and the EBMT are excited to announce the 7th edition of the jointly organized European CAR T-cell Meeting.

Read more

Previous Meetings

All of the meetings on this page took place in 2025. The most recent meetings are listed first. To view meetings from previous years, use the navigation menu.

Read more

Registration

Registration is now closed.

Read more

Lighting the Flame program

Spark your interest in hematology by joining our free training program for medical students, interns, and residents who have not yet chosen a specialty.

Read more

EHA-SWG Scientific Meeting on Recent Advances in the Pathogenesis and Treatment of Secondary Acute Myeloid Leukemias

Dates: April 25-26, 2025
Location: Berlin, Germany
Chairs: K Döhner, P Vyas, and MT Voso
Collaborating SWG: EHA Specialized Working Group on Acute Myeloid Leukemia

Registration is now open

OverviewThe EHA-SWG Scientific Meeting on Recent Advances in the Pathogenesis and Treatment of Secondary Acute Myeloid Leukemias (sAML) will focus…

Read more

EHA Exam

EHA Exam 2025
The 9th European Hematology Exam will take place on June 12, 2025, from 13:30–16:00 (CEST). Main exam session
The main exam session will be held during the EHA2025 Hybrid Congress in Milan, Italy.

Read more

Publications

HemaSphere - the official open access journal of EHAHemaSphere is the official open access, peer-reviewed journal of EHA, supporting hematology researchers by offering a fast and constructive review process and low publication fees.

Read more

EHA Mentorship Program

A new, career-focused program that provides individual mentoring support for early and mid-career clinicians and researchers in hematology. The call for mentees closed on February 20, 2025.

Read more

CAR NK-cells project, February 2025 update

A project update from Dr Ciprian Tomuleasa. We successfully designed and tested in vitro CAR T and CAR NK cells, transfected with the iCas9 suicide trigger.

Read more